Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60K Sell
218
-4
-2% -$1.13K 0.02% 185
2026
Q1
$59.3K Sell
222
-4
-2% -$1.11K 0.03% 164
2025
Q4
$62.3K Sell
226
-4
-2% -$1.12K 0.03% 159
2025
Q3
$66.4K Sell
230
-4
-2% -$1.18K 0.03% 149
2025
Q2
$77.5K Buy
234
+1
+0.4% +$322 0.04% 123
2025
Q1
$76.8K Sell
233
-7
-3% -$2.11K 0.04% 116
2024
Q4
$66.1K Buy
240
+1
+0.4% +$319 0.04% 129
2024
Q3
$82.7K Sell
239
-5
-2% -$1.72K 0.05% 105
2024
Q2
$80.6K Sell
244
-3
-1% -$1.03K 0.05% 100
2024
Q1
$89.7K Sell
247
-1
-0.4% -$329 0.06% 94
2023
Q4
$74.4K Hold
248
0.05% 105
2023
Q3
$70.8K Buy
248
+1
+0.4% +$285 0.06% 86
2023
Q2
$69.3K Buy
247
+1
+0.4% +$260 0.06% 88
2023
Q1
$62.9K Buy
246
+1
+0.4% +$291 0.06% 84
2022
Q4
$81.2K Hold
245
0.09% 61
2022
Q3
$67.9K Buy
245
+1
+0.4% +$281 0.07% 70
2022
Q2
$64.3K Buy
244
+1
+0.4% +$258 0.06% 76
2022
Q1
$58.2K Buy
243
+1
+0.4% +$234 0.05% 83
2021
Q4
$55.6K Buy
+242
New +$51.4K 0.04% 93

Other funds holding CI

PFS Partners's CI Position: Q2 2026 in Review

PFS Partners reduced its Cigna (CI) stake by 1.8% in Q2 2026, selling an estimated $1.13K and leaving 218 shares worth $60K. The position accounts for 0.02% of the portfolio, ranked #185.

PFS Partners first reported a position in CI in Q4 2021 and has held it in 19 quarters since. The position peaked at $89.7K in Q1 2024. 476 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • PFS Partners held 218 shares of Cigna worth $60K as of Q2 2026.
  • PFS Partners sold 4 Cigna shares in Q2 2026, an estimated $1.13K.
  • Cigna made up 0.02% of PFS Partners's portfolio in Q2 2026, its #185 holding.
  • PFS Partners first reported a position in Cigna in Q4 2021 and has held it in 19 quarters since.
  • PFS Partners's Cigna position peaked at $89.7K in Q1 2024.
  • 476 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on PFS Partners's 13F filing for Q2 2026, filed 20 Jul 2026.